Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VENTXP2 is a member of the VENT homeobox gene family and is classified as a pseudogene, meaning it is a non-functional genomic sequence derived from a once-protein-coding gene. Pseudogenes generally result from duplication or retrotransposition events and typically lack necessary regulatory sequences or accumulate disabling mutations such as frameshifts or premature stop codons. VENTXP2 does not produce a functional protein and, unlike its functional family member VENTX, does not act as a transcription factor, nor is it involved in development or disease. The confusion may arise from the similarity to VENTX, which is a functional homeobox gene implicated in hematopoiesis and leukemia, but VENTXP2 itself lacks any known biological function, role in disease, or therapeutic relevance. VENTXP2’s gene locus is located on chromosome 13q31.1. Note: If a functional VENTX homeobox gene target is intended, you should refer to “VENTX” and not “VENTXP2”; “VENTXP2” refers only to the pseudogene sequence and is not a drug/protein target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on VENT homeobox pseudogene 2 (VENTXP2).